YIH
APLT

Y-Intercept (HK)’s Applied Therapeutics APLT Stock Holding History

Y-Intercept (HK)’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,542
Closed -$149K – 1155
2024
Q3 		$149K Buy
+17,542
New +$103K 0.01% 1196
2024
Q2 		– Sell
-27,017
Closed -$184K – 1370
2024
Q1 		$184K Buy
27,017
+15,969
+145% +$71.7K 0.01% 1181
2023
Q4 		$37K Buy
+11,048
New +$27.5K ﹤0.01% 1170

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Y-Intercept (HK)'s APLT Position: Q4 2024 in Review

Y-Intercept (HK) sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 17,542 shares — an estimated $149K sold.

Y-Intercept (HK) first reported a position in APLT in Q4 2023 and held it in 3 quarters. The position peaked at $184K in Q1 2024. 119 funds tracked by Wall St. Rank hold APLT as of Q4 2024.

  • Y-Intercept (HK) reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 17,542 Applied Therapeutics shares in Q4 2024, an estimated $149K.
  • Y-Intercept (HK) first reported a position in Applied Therapeutics in Q4 2023 and held it in 3 quarters.
  • Y-Intercept (HK)'s Applied Therapeutics position peaked at $184K in Q1 2024.
  • 119 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.

Based on Y-Intercept (HK)'s 13F filing for Q4 2024, filed 4 Feb 2025.